Pricing
Kalgene is developing a novel fusion protein therapeutic for slowing the progression of Alzheimer’s disease, with technology licensed from the National Research Council of Canada.
Industries
Headquarters
Employees
Links
Org chart
Teams
Offices
Positions (5)
Unverified
0 people · 0 jobs
HQ
Astellas Pharma
49 followers
Tilray
19 followers
Knight Therapeutics
1 follower
AstraZeneca
510 followers
Bayer
435 followers
Bristol-Myers Squibb
294 followers
UCB
77 followers
NYU Langone Health
39 followers
Perrigo
West Pharmaceutical Services
11 followers
Dechra Pharmaceuticals
10 followers
View more